ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.

J Exp Clin Cancer Res · 2021 · PMC8086123 · PMID 33931075

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an obvious trendno p-value reported

S 7 C-D showed that an obvious trend was observable in Luminal &RT, Non-luminal &RT, and Non-luminal &NRT subgroups, but not in Luminal &NRT.

also in 1,006 other papers

showed a trendno p-value reported

S 7 H showed a trend for the subgroup TP53(−) & ALG3(Low) but it was not significant for outcome after RT in the other subgroups, which was consistent with that both TP53 mutation [ 85 ] and ALG3 overexpression would significantly influence the radiosensitivity of breast cancer.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.